Literature DB >> 6161204

Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.

T J Williams, P J Jose.   

Abstract

Intradermal injection of zymosan into nonsensitized rabbits induces plasma exudation, which is dependent on two mediators: C5a generated in extravascular tissue fluid and a vasodilator prostaglandin generated from substrates localized in cell membranes. This relationship between the complement system and the prostaglandin synthesis system had not previously been explored, and complement activation has generally been associated with increased vascular permeability via histamine release. We report that C5a increases vascular permeability by a mechanism that is not dependent on histamine release; however plasma exudation is virtually undetectable in the absence of a vasodilator substance. Because the permeability-increasing activity is stable in plasma, analogy with other species suggests that the activity is a result of C5a devoid of its carboxyl terminal arginine (C5a des Arg). This relates the observed permeability-increasing activity with effects on leukocytes rather than effects as an anaphylatoxin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161204      PMCID: PMC2186055          DOI: 10.1084/jem.153.1.136

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

Review 1.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

2.  Complement activation and hematologic, hemodynamic, and respiratory reactions early after soft-tissue injury.

Authors:  M Heideman; B Kaijser; L E Gelin
Journal:  J Trauma       Date:  1978-10

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Prostaglandins as potentiators of increased vascular permeability in inflammation.

Authors:  T J Williams; J Morley
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

5.  [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin].

Authors:  G Bodammer; W Vogt
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

6.  Preparation and some properties of anaphylatoxin from hog serum.

Authors:  W Vogt
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor.

Authors:  R Snyderman; J Phillips; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

9.  Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors:  W Dias Da Silva; I H Lepow
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  52 in total

1.  The role of CD18 in IL-8 induced dermal and synovial inflammation.

Authors:  M J Forrest; G J Eiermann; R Meurer; L A Walakovits; D E MacIntyre
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

2.  Mechanism of prostaglandin E2 inhibition of acute changes in vascular permeability.

Authors:  K R McLeish; S R Wellhausen; G T Stelzer
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

3.  Inhibitory effects of methyl 7-butyl-4,5,6,7-tetrahydro-3-methylamino-4,6-dioxo-5-propyl- 2H-pyrazolo[3,4-d]pyrimidine-2-carboxylate (AA-2379) on lysosomal enzyme and arachidonic acid release from rat polymorphonuclear leukocytes and its mode of action.

Authors:  H Makino; T Saijo; Y Maki
Journal:  Agents Actions       Date:  1989-11

4.  Leucocytes activated by C5a des Arg promote endothelial prostacyclin (PGI2) production via release of oxygen species in vitro.

Authors:  M Rampart; P J Jose; T J Williams
Journal:  Agents Actions       Date:  1985-03

5.  Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

Authors:  T Imamura; T Yamamoto; T Kambara
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

6.  Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

7.  Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.

Authors:  F Pons; A G Rossi; K E Norman; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

8.  A new assay for antiphlogistic activity: zymosan-induced mouse ear inflammation.

Authors:  F Erdö; K Török; P Arányi; J I Székely
Journal:  Agents Actions       Date:  1993-07

9.  Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.

Authors:  M Rampart; T J Williams
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

Review 10.  Leukotrienes, allergy and inflammation.

Authors:  F P Nijkamp; J M Sitsen
Journal:  Pharm Weekbl Sci       Date:  1982-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.